ABBV - AbbVie Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
128.55B
Enterprise Value 3
156.44B
Trailing P/E
39.93
Forward P/E 1
8.92
PEG Ratio (5 yr expected) 1
2.65
Price/Sales (ttm)
3.91
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
4.76
Enterprise Value/EBITDA 6
10.12

Trading Information

Stock Price History

Beta (3Y Monthly) 0.95
52-Week Change 3-0.72%
S&P500 52-Week Change 319.27%
52 Week High 392.99
52 Week Low 362.66
50-Day Moving Average 384.00
200-Day Moving Average 374.46

Share Statistics

Avg Vol (3 month) 37.75M
Avg Vol (10 day) 36.32M
Shares Outstanding 51.48B
Float 1.48B
% Held by Insiders 10.09%
% Held by Institutions 171.89%
Shares Short (Nov 15, 2019) 470.93M
Short Ratio (Nov 15, 2019) 48.84
Short % of Float (Nov 15, 2019) 45.44%
Short % of Shares Outstanding (Nov 15, 2019) 44.80%
Shares Short (prior month Oct 15, 2019) 463.49M

Dividends & Splits

Forward Annual Dividend Rate 44.72
Forward Annual Dividend Yield 45.44%
Trailing Annual Dividend Rate 34.28
Trailing Annual Dividend Yield 34.92%
5 Year Average Dividend Yield 43.69
Payout Ratio 4183.70%
Dividend Date 3Feb 14, 2020
Ex-Dividend Date 4Jan 14, 2020
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 9.90%
Operating Margin (ttm)41.11%

Management Effectiveness

Return on Assets (ttm)13.45%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)32.87B
Revenue Per Share (ttm)22.15
Quarterly Revenue Growth (yoy)3.00%
Gross Profit (ttm)25.04B
EBITDA 15.46B
Net Income Avi to Common (ttm)3.23B
Diluted EPS (ttm)2.18
Quarterly Earnings Growth (yoy)-31.40%

Balance Sheet

Total Cash (mrq)10.65B
Total Cash Per Share (mrq)7.2
Total Debt (mrq)38.84B
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.15
Book Value Per Share (mrq)-5.56

Cash Flow Statement

Operating Cash Flow (ttm)13.44B
Levered Free Cash Flow (ttm)10.29B